Quantcast

Latest Organic chemistry Stories

2014-07-07 23:05:07

Market Size - $4,301.6 mn in 2013, Market Growth - CAGR of 6.8%, Market Trends –Increasing automobile sales in Asia Pacific. View full report with TOC - http://www.grandviewresearch.com/industry-analysis/maleic-anhydride-market. San Francisco, California (PRWEB) July 07, 2014 The global market for maleic anhydride is expected to reach USD 6,788.8 million by 2020, according to a new study by Grand View Research, Inc. Increasing demand for unsaturated polyester resins and BDO is expected...

2014-07-07 23:00:59

Launch of the Risperdal Lawsuits for Gynecomastia Page Comes as Hundreds of Plaintiffs Seek Compensation for Gynecomastia, a Condition Marked by the Excessive Growth of Male Breast Tissue, Which is Allegedly Caused by Risperdal. Chicago IL (PRWEB) July 07, 2014 The Oliver Law Group P.C. a harmful drug law firm, announces that they have launched a Risperdal lawsuit for Gynecomastia page in response to the growing Risperdal gynecomastia litigation underway in Pennsylvania state court. Court...

2014-07-07 12:22:02

DALLAS, July 7, 2014 /PRNewswire/ -- According to a new market research report entitled, "Herbicides Market by Type (Glyphosate, Atrazine, Acetochlor, 2, 4-D), by Crop Type (Cereals & Grains, Oilseeds & Pulses, Fruits & Vegetables), by Mode of Action (Selective & Non-selective) & Geography - Trends and Forecasts to 2019", the Herbicides Market is projected to grow from $21,065.2 Million in 2013 to $29,976.1 Million by 2019, at a CAGR of 6.2% from 2014 to...

2014-07-07 11:39:51

European League Against Rheumatism Slower dose tapering and absence of positive serology reduce risk of flare A new study presented today at the European League Against Rheumatism Annual Congress (EULAR 2014) showed that, for the majority of lupus patients who are in remission, it is possible to successfully stop immunosuppressant therapy without triggering a flare of their disease. Within two years, it was possible to stop the immunosuppressant in about 70% of clinically stable...

2014-07-07 08:22:14

-- Nexavar is the only approved treatment for patients with RAI-refractory differentiated thyroid cancer -- Nexavar significantly extended progression-free survival in patients with RAI-refractory differentiated thyroid cancer compared to placebo in the Phase III DECISION trial TORONTO, July 7, 2014 /CNW/ - Bayer Inc. is pleased to announce the Health Canada approval of Nexavar for the treatment of patients with locally...

2014-07-06 16:21:01

DALLAS, July 6, 2014 /PRNewswire/ -- 2014 Deep Research Report on Global and China Polyether Block Amide (PEBA) Industry published in July 2014 is spread across 164 pages and comes with 138 data tables and figures on the market. Companies like Evonik, Arkema and EMS have been profiled in this business intelligence study providing forecasts for the duration of 2014-2019. This PEBA (polyether block amide) market report ( http://www.deepresearchreports.com/111730.html )...

2014-07-03 23:01:24

Harbor Village Florida comments on on a study that reduces relapses from heroin. USA (PRWEB) July 03, 2014 Patients that begin treatment for heroin and opioid addiction during hospitalization that also receive outpatient treatment (medical and psychiatric) are 5x less likely to relapse, according to a recent report “Treating Addicted Patients During, After Hospitalization Reduces Relapse” (6/30). According to the report, the average bill for opioid and heroin-related treatment in 2013...

2014-07-03 23:01:07

The Firm is representing a number of Risperdal lawsuit clients in the Pennsylvania litigation who allegedly developed gynecomastia (male breast growth) due to their use of the atypical antipsychotic drug. New York, New York (PRWEB) July 03, 2014 Risperdal lawsuits (http://www.risperdallawsuitcenter.com/) that allege the atypical antipsychotic medication caused gynecomastia (male breast growth) in men and boys continue to move forward in a mass tort proceeding underway in Pennsylvania’s...

2014-07-03 20:20:02

Tokyo, July 3, 2014 - (JCN Newswire) - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") announced today that it has received approval from the European Commission of the indication expansion of Halaven (generic name: eribulin mesylate, "eribulin") to contribute to earlier treatment of patients with locally advanced or metastatic breast cancer who have progressed after at least one chemotherapeutic regimen for advanced disease. Prior therapy should...

2014-07-03 11:43:01

BMJ-British Medical Journal Consumption of illicit drugs might dwarf the consumption of legitimate versions At least two-thirds of the erectile dysfunction drug sildenafil (e.g. Viagra) consumed in the Netherlands may be illegal, warn researchers today. In a letter published on bmj.com, they say the consumption of illicit drugs might dwarf consumption of legitimate versions – and they call for the further inquiry into the apparent success of rogue online pharmacies. It follows...


Latest Organic chemistry Reference Libraries

Organometallics
2012-05-17 15:18:17

Organometallics is a peer-reviewed scientific journal published by the American Chemical Society. As of May 2012, the editor-in-chief is John A. Gladysz. Organometallics publishes records in one of the most active fields for organometallic, inorganic, organic, and materials chemists. Articles, communications, mini-reviews, and notes detail the synthesis, structure, bonding, chemical reactivity and reaction mechanisms, and applications of organometallic and organometalloidal compounds....

Synthetic Metals
2012-05-17 14:54:38

Synthetic Metals is a peer-reviewed scientific journal published by Elsevier. It covers all aspects of electronic polymers and electronic molecular materials. It is an international medium for the rapid publication of original research papers, short communications and subject reviews dealing with research on and applications of electronic polymers and electronic molecular materials including novel carbon architectures. Original manuscripts on chemical, electrochemical, electrical, photonic...

More Articles (2 articles) »
Word of the Day
lunula
  • A small crescent-shaped structure or marking, especially the white area at the base of a fingernail that resembles a half-moon.
This word is a diminutive of the Latin 'luna,' moon.
Related